Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof
Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637)
11/2003
11/20/2003US20030215948 Comprises adenoviral particle with reduced binding responses to heparin sulfate proteoglycans (HSP) for use as tools in gene therapy and genetic engineering
11/20/2003US20030215796 Detecting and differentiating viruses or intracellular parasites present in a specimen; inoculating culture with pathogen and observing for its presence
11/20/2003US20030215793 Complete genome sequence of a simian immunodeficiency virus from a wild chimpanzee
11/20/2003US20030215466 Which is incapable of reproduction within human cell lines; for treatment of human immunodeficency virus
11/20/2003US20030215422 Aav4 vector and uses thereof
11/20/2003CA2485655A1 Recombinant fowlpox virus
11/19/2003EP1361889A1 Novel vaccine
11/19/2003EP1047446B1 Vaccine composition for herpes simplex virus and methods of using
11/19/2003CN1456665A Production of organic phosphorous chemicals decomposing enzyme by silkworm bioreactor
11/19/2003CN1456355A Forest cerebritis purifying vaccinum
11/19/2003CN1128218C Rotavirus causing adult's diarrhea and its culture process
11/18/2003US6649410 Method for the development of an HIV vaccine
11/18/2003US6649409 Method for producing a nucleotide sequence construct with optimized codons for an HIV genetic vaccine based on a primary, early HIV isolate and synthetic envelope BX08 constructs
11/18/2003US6649396 Fiber receptor-independent system for the propagation of adenoviral vectors
11/18/2003US6649372 Which expresses heterologous nucleotide sequences; introducing expression vectors, nucleotprotein, and polymerase into a cell; allowing complex to form; culturing; use in vaccines
11/18/2003US6649169 Cold-adapted equine influenza viruses
11/18/2003US6649157 Treating a Ras-mediated cell proliferative disorder in a mammal, by administering a modified adenovirus, modified HSV, modified vaccinia virus or modified parapoxvirus orf virus resulting in lysis of the proliferating cells.
11/18/2003CA2143845C Self-assembling recombinant papillomavirus capsid proteins
11/13/2003WO2003093512A1 Methods and compositions for the modification of nucleic acids
11/13/2003WO2003093463A1 Improved viral purification methods
11/13/2003WO2003093461A2 Genomic library of cyanophage s-2l and functional analysis
11/13/2003WO2003093460A1 Method for direct rescue and amplification of integrated viruses from cellular dna of tissues
11/13/2003WO2003093431A2 Ablated slam-dependent entry
11/13/2003WO2003092708A1 Antitumor agents with the use of hsv
11/13/2003WO2003092594A2 Adeno-associated viral vectors and methods for their production from hybrid adenovirus and for their use
11/13/2003WO2003092592A2 Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3'-utr of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4
11/13/2003WO2003092582A2 Chimeric ebola virus envelopes and uses therefor
11/13/2003WO2003068804A3 Novel insect cell line
11/13/2003WO2003024502A3 Compositions and methods useful for non-invasive delivery of therapeutic molecules to the bloodstream
11/13/2003WO2002097056A3 Method for generating replication defective viral vectors that are helper free
11/13/2003WO2002057302A8 A virus causing respiratory tract illness in susceptible mammals
11/13/2003WO2002014362A3 A hepatitis c virus non-structural ns3/4a fusion gene
11/13/2003US20030212030 Blood disorders; synergistic mixture of vector and monoclonal antibody
11/13/2003US20030211996 Virus like particles
11/13/2003US20030211614 Using genetically engineered adeno-associated viral vector to transfer hereditary material into cells; gene therapy
11/13/2003US20030211597 Genetically engineered hepatitis C viral (HVC) particle for use in prevention, diagnosis and prognostication of viral infections; immunoassays; genetic vaccines diagnosis
11/13/2003CA2484940A1 Methods and compositions for the modification of nucleic acids
11/13/2003CA2483706A1 Genomic library of cyanophage s-2l and functional analysis
11/13/2003CA2483653A1 Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3'-utr of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4
11/12/2003EP1360276A2 In vitro system for replication of rna-dependent rna polymerase (rdrp) viruses
11/12/2003EP0804163B1 Improved method for stabilization of biological substances during drying and subsequent storage and compositions thereof
11/12/2003CN1455816A Rescue of canine distemper virus from CDNA
11/11/2003US6645760 Negative strand RNA viral vector having autonomous replication capability
11/11/2003CA2259594C Subunit respiratory syncytial virus vaccine preparation
11/11/2003CA2210294C Immunogenic compositions containing recombinant attenuated poxviruses expressing htlv antigens
11/06/2003WO2003091459A1 Cells for detection of influenza and parainfluenza viruses
11/06/2003WO2003091425A1 Novel 33 phage vectors
11/06/2003WO2003091401A2 Multi plasmid system for the production of influenza virus
11/06/2003WO2003091386A2 A new family of picornaviruses
11/06/2003WO2003049766A3 Method of purifying hepatitis a virus particles and vaccine preparation
11/06/2003WO2003023021A3 Methods for producing an active constituent of a pharmaceutical or a diagnostic agent in an mdck cell suspension culture
11/06/2003WO2003008564A3 Methods of polyvalent bacteriophage preparation for the treatment of bacterial infections
11/06/2003WO2002096939A3 Adenovirus protein ix, its domains involved in capsid assembly, transcriptional activity and nuclear reorganization
11/06/2003WO2002018369A8 Peptidomimetic protease inhibitors
11/06/2003US20030207446 Infectious papillomavirus pseudoviral particles
11/06/2003US20030207439 Large-scale recombinant adeno-associated virus (rAAV) production and purification
11/06/2003US20030207380 For diagnosis and treatment of estrogenic disorder of mutant ER alpha
11/06/2003US20030207259 By transfecting cellular DNA into cells
11/06/2003US20030206926 Characterized by the loss of its capability to reproductively replicate in human cell lines.
11/06/2003US20030206925 Isolated, recombinantly-generated, negative-sense, single-stranded RNA viruses having one or more mutations and/or deletions which reduce repression normally caused by V protein
11/06/2003US20030206924 Equine herpesvirus vaccine
11/06/2003US20030206919 Hepatitis C virus codon optimized non-structural NS3/4A fusion gene
11/06/2003US20030206888 Herpes simplex virus strains
11/06/2003CA2827114A1 Multi plasmid system for the production of influenza virus
11/06/2003CA2483747A1 Cells for detection of influenza and parainfluenza viruses
11/06/2003CA2482946A1 Multi plasmid system for the production of influenza virus
11/06/2003CA2448574A1 Novel 33 phage vectors
11/05/2003EP1359223A2 Recombinant AAV preparation substantially free of wt aav virus
11/05/2003EP1359217A1 Method for direct rescue and amplification of integrated viruses from cellular DNA of tissues
11/05/2003EP1359156A2 Papilloma virus vaccine
11/05/2003EP1358319A2 Live influenza vaccine and method of manufacture
11/05/2003EP1357796A2 Control agents
11/05/2003CN1453361A Construction method of virus as anticancer targeting adjustable gene
11/05/2003CN1453360A Method of constituting novel recombinant HIV vector to kill HIV infected cells specifically under unique regulation mode
11/05/2003CN1126816C Method for large scale production of recombined-adenovirus accompanying virus and application thereof
11/05/2003CN1126569C Low pathogenicity PRRS live virus vaccines and methods of preparation thereof
11/04/2003US6642207 Artificial chromosome constructs containing foreign nucleic acid sequences
11/04/2003US6642052 Generating genetically engineered viral particle; obtain viral genome, incubate with regulatory sequences, allow homologous recombination transfect cells, recover genetically engineered viral particle
11/04/2003US6642026 Method of producing biologically active human acidic fibroblast growth factor and its use in promoting angiogenesis
11/04/2003US6641819 Porcine reproductive and respiratory syndrome vaccine, based on isolate JA-142
11/04/2003US6641818 Cellular proteins which mediate herpesvirus entry
11/04/2003US6641817 Herpes virus vectors for dendritic cells
11/04/2003US6641816 Use of poxviruses as enhancer of specific immunity
11/04/2003US6641807 Helper dependent adenoviral vectors encoding erythropoietin provide high levels of epo to achieve a long-term therapeutically effective dosage, and allow for repeat administration to patients with disorders such as anaemia of
11/04/2003CA2085191C Vaccines based on modified type 1 bovine herpesviruses
10/2003
10/30/2003WO2003089612A2 IMPROVED rAAV VECTORS
10/30/2003WO2003089015A2 Rapid sterilization and vaccine preparation
10/30/2003WO2003088994A2 Modified vaccinia virus ankara for the vaccination of neonates
10/30/2003WO2003088899A2 Methods for the production of chimeric adeno-associated virus (aav) vectors, compositions of chimeric aav vectors, and methods of use thereof
10/30/2003WO2003063725A3 Methods of preventing and treating flavivirus infection in animals
10/30/2003WO2003046142A3 Methods for producing stocks of recombinant aav virions
10/30/2003WO2003029274A3 Paramyxoviruses as gene transfer vectors to lung cells
10/30/2003WO2003020879A3 Cells and methods for propagating adenoviral vectors
10/30/2003WO2003004661A3 Adenovital vectors with cell type specificity for mesenchymal cells
10/30/2003WO2002072851A3 Lentiviral packaging constructs
10/30/2003WO2002062965A3 Method for identifying intercellular protein factors
10/30/2003WO2002007742A8 Bacteriophage having multiple host range
10/30/2003WO2001090302A3 Compositions and methods for production of rna viruses and rna virus-based vector particles
10/30/2003US20030203861 Nucleic acid vector containing a non-coding, immunostimulatory polynucleotide, comprised of six nucleotides arranged in the sequence 5'-purine-purine-unmethylated CpG-pyrimidine-pyrimidine-3'
10/30/2003US20030203488 Plasmid comprising components from herpesvirus, cytomegalovirus, adeno-associated virus, poxvirus and adenovirus which permits the transfer and expression of genes of interest in preferential cells
1 ... 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 ... 267